{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:14:04Z","timestamp":1795061644319,"version":"4.10.2"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM128997"],"award-info":[{"award-number":["R01GM128997"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM148182"],"award-info":[{"award-number":["R35GM148182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA056365"],"award-info":[{"award-number":["R01DA056365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32MH112507"],"award-info":[{"award-number":["T32MH112507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM113770"],"award-info":[{"award-number":["T32GM113770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM099608"],"award-info":[{"award-number":["T32GM099608"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R44MH119989"],"award-info":[{"award-number":["R44MH119989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM133421"],"award-info":[{"award-number":["R35GM133421"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH130591"],"award-info":[{"award-number":["R01MH130591"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P50DA042012"],"award-info":[{"award-number":["P50DA042012"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM119831"],"award-info":[{"award-number":["R35GM119831"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DP2MH136588"],"award-info":[{"award-number":["DP2MH136588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001082","name":"Camille and Henry Dreyfus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010336","name":"Hellman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boone Family Foundation; WoodNext Foundation, Delix Therapeutics"},{"DOI":"10.13039\/100007707","name":"UC | University of California, Davis","doi-asserted-by":"publisher","award":["Human Genetics Focus Group grant"],"award-info":[{"award-number":["Human Genetics Focus Group grant"]}],"id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"UC | University of California, Davis","doi-asserted-by":"publisher","award":["Human Genetics Focus Group grant"],"award-info":[{"award-number":["Human Genetics Focus Group grant"]}],"id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"UC | University of California, Davis","doi-asserted-by":"publisher","award":["Davis Provost\u2019s Undergraduate Fellowship"],"award-info":[{"award-number":["Davis Provost\u2019s Undergraduate Fellowship"]}],"id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"UC | University of California, Davis","doi-asserted-by":"publisher","award":["Human Genetics Focus Group grant"],"award-info":[{"award-number":["Human Genetics Focus Group grant"]}],"id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","award":["202210MFE-491520-297096"],"award-info":[{"award-number":["202210MFE-491520-297096"]}],"id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boone Family Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41593-025-02021-1","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T14:04:15Z","timestamp":1754316255000},"page":"1919-1931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation"],"prefix":"10.1038","volume":"28","author":[{"given":"Isak K.","family":"Aarrestad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8420-7898","authenticated-orcid":false,"given":"Lindsay P.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan M.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-851X","authenticated-orcid":false,"given":"Austen B.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-0730","authenticated-orcid":false,"given":"Daniel R.","family":"Rijsketic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seona D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Sambyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-9726","authenticated-orcid":false,"given":"Shane B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashri","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden V.","family":"Barragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Seban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0497-4796","authenticated-orcid":false,"given":"Hongru","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Chytil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retsina","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-7627","authenticated-orcid":false,"given":"Hanne D.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3240-0223","authenticated-orcid":false,"given":"Clara A.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-6866","authenticated-orcid":false,"given":"Gitte M.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Redd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian G.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Guanzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-4695","authenticated-orcid":false,"given":"Joseph J.","family":"Hennessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1716-0153","authenticated-orcid":false,"given":"Gerald","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-9413","authenticated-orcid":false,"given":"John D.","family":"McCorvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil P.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1639-5401","authenticated-orcid":false,"given":"Conor","family":"Liston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7287-0748","authenticated-orcid":false,"given":"John A.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1474-0379","authenticated-orcid":false,"given":"Boris D.","family":"Heifets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4259-7514","authenticated-orcid":false,"given":"Alex S.","family":"Nord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-7098","authenticated-orcid":false,"given":"Christina K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4517-0543","authenticated-orcid":false,"given":"David E.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"2021_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman, R. S., Aghajanian, G. K., Sanacora, G. & Krystal, J. H. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat. Med. 22, 238\u2013249 (2016).","journal-title":"Nat. Med."},{"key":"2021_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ynstr.2014.10.002","volume":"1","author":"AFT Arnsten","year":"2015","unstructured":"Arnsten, A. F. T., Raskind, M. A., Taylor, F. B. & Connor, D. F. The effects of stress exposure on prefrontal cortex: translating basic research into successful treatments for post-traumatic stress disorder. Neurobiol. Stress 1, 89\u201399 (2015).","journal-title":"Neurobiol. Stress"},{"key":"2021_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","volume":"12","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein, R. Z. & Volkow, N. D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 12, 652\u2013669 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"2021_CR4","doi-asserted-by":"publisher","first-page":"727117","DOI":"10.3389\/fpsyt.2021.727117","volume":"12","author":"MV Vargas","year":"2021","unstructured":"Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M. & Olson, D. E. Psychedelics and other psychoplastogens for treating mental illness. Front. Psychiatry 12, 727117 (2021).","journal-title":"Front. Psychiatry"},{"key":"2021_CR5","doi-asserted-by":"publisher","first-page":"117906951880050","DOI":"10.1177\/1179069518800508","volume":"12","author":"DE Olson","year":"2018","unstructured":"Olson, D. E. Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics. J. Exp. Neurosci. 12, 1179069518800508 (2018).","journal-title":"J. Exp. Neurosci."},{"key":"2021_CR6","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly, C. et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 23, 3170\u20133182 (2018).","journal-title":"Cell Rep."},{"key":"2021_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","volume":"73","author":"A Inserra","year":"2021","unstructured":"Inserra, A., De Gregorio, D. & Gobbi, G. Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms. Pharmacol. Rev. 73, 202\u2013277 (2021).","journal-title":"Pharmacol. Rev."},{"key":"2021_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","volume":"78","author":"AK Davis","year":"2021","unstructured":"Davis, A. K. et al. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry 78, 481\u2013489 (2021).","journal-title":"JAMA Psychiatry"},{"key":"2021_CR9","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris, R. et al. Trial of psilocybin versus escitalopram for depression. N. Engl. J. Med. 384, 1402\u20131411 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2021_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"R Carhart-Harris","year":"2018","unstructured":"Carhart-Harris, R. et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl.) 235, 399\u2013408 (2018).","journal-title":"Psychopharmacology (Berl.)"},{"key":"2021_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","volume":"11","author":"M Hibicke","year":"2020","unstructured":"Hibicke, M., Landry, A. N., Kramer, H. M., Talman, Z. K. & Nichols, C. D. Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression. ACS Chem. Neurosci. 11, 864\u2013871 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"2021_CR12","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"L-X Shao","year":"2021","unstructured":"Shao, L.-X. et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 109, 2535\u20132544 (2021).","journal-title":"Neuron"},{"key":"2021_CR13","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","volume":"9","author":"LP Cameron","year":"2018","unstructured":"Cameron, L. P., Benson, C. J., Dunlap, L. E. & Olson, D. E. Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression. ACS Chem. Neurosci. 9, 1582\u20131590 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"2021_CR14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","volume":"42","author":"LR Aleksandrova","year":"2021","unstructured":"Aleksandrova, L. R. & Phillips, A. G. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Trends Pharmacol. Sci. 42, 929\u2013942 (2021).","journal-title":"Trends Pharmacol. Sci."},{"key":"2021_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0269881108094300","volume":"22","author":"RR Griffiths","year":"2008","unstructured":"Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U. D. & Jesse, R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J. Psychopharmacol. 22, 621\u2013632 (2008).","journal-title":"J. Psychopharmacol."},{"key":"2021_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1021\/acs.jmedchem.9b01404","volume":"63","author":"LE Dunlap","year":"2020","unstructured":"Dunlap, L. E. et al. Identification of psychoplastogenic N, N-dimethylaminoisotryptamine (isoDMT) analogues through structure\u2013activity relationship studies. J. Med. Chem. 63, 1142\u20131155 (2020).","journal-title":"J. Med. Chem."},{"key":"2021_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","volume":"589","author":"LP Cameron","year":"2021","unstructured":"Cameron, L. P. et al. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature 589, 474\u2013479 (2021).","journal-title":"Nature"},{"key":"2021_CR18","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/j.cell.2021.03.043","volume":"184","author":"C Dong","year":"2021","unstructured":"Dong, C. et al. Psychedelic-inspired drug discovery using an engineered biosensor. Cell 184, 2779\u20132792 (2021).","journal-title":"Cell"},{"key":"2021_CR19","doi-asserted-by":"publisher","first-page":"112203","DOI":"10.1016\/j.celrep.2023.112203","volume":"42","author":"V Lewis","year":"2023","unstructured":"Lewis, V. et al. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Cell Rep. 42, 112203 (2023).","journal-title":"Cell Rep."},{"key":"2021_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","volume":"4","author":"DB Yaden","year":"2020","unstructured":"Yaden, D. B. & Griffiths, R. R. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol. Transl. Sci. 4, 568\u2013572 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2021_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","volume":"4","author":"DE Olson","year":"2020","unstructured":"Olson, D. E. The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharmacol. Transl. Sci. 4, 563\u2013567 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2021_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.biopsych.2021.05.008","volume":"90","author":"E Castr\u00e9n","year":"2021","unstructured":"Castr\u00e9n, E. & Monteggia, L. M. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol. Psychiatry 90, 128\u2013136 (2021).","journal-title":"Biol. Psychiatry"},{"key":"2021_CR23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/mp.2017.61","volume":"22","author":"E Castr\u00e9n","year":"2017","unstructured":"Castr\u00e9n, E. & Antila, H. Neuronal plasticity and neurotrophic factors in drug responses. Mol. Psychiatry 22, 1085\u20131095 (2017).","journal-title":"Mol. Psychiatry"},{"key":"2021_CR24","doi-asserted-by":"publisher","first-page":"eaat8078","DOI":"10.1126\/science.aat8078","volume":"364","author":"RN Moda-Sava","year":"2019","unstructured":"Moda-Sava, R. N. et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science 364, eaat8078 (2019).","journal-title":"Science"},{"key":"2021_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1021\/acsptsci.0c00065","volume":"4","author":"C Ly","year":"2020","unstructured":"Ly, C. et al. Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth. ACS Pharmacol. Transl. Sci. 4, 452\u2013460 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2021_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","volume":"61","author":"DE Olson","year":"2022","unstructured":"Olson, D. E. Biochemical mechanisms underlying psychedelic-induced neuroplasticity. Biochemistry 61, 127\u2013136 (2022).","journal-title":"Biochemistry"},{"key":"2021_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ijnp\/pyaa087","volume":"24","author":"B Kadriu","year":"2021","unstructured":"Kadriu, B. et al. Ketamine and serotonergic psychedelics: common mechanisms underlying the effects of rapid-acting antidepressants. Int. J. Neuropsychopharmacol. 24, 8\u201321 (2021).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"2021_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.tins.2020.11.008","volume":"44","author":"NK Savalia","year":"2021","unstructured":"Savalia, N. K., Shao, L.-X. & Kwan, A. C. A dendrite-focused framework for understanding the actions of ketamine and psychedelics. Trends Neurosci. 44, 260\u2013275 (2021).","journal-title":"Trends Neurosci."},{"key":"2021_CR29","doi-asserted-by":"publisher","first-page":"e2020705118","DOI":"10.1073\/pnas.2020705118","volume":"118","author":"D De Gregorio","year":"2021","unstructured":"De Gregorio, D. et al. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. Proc. Natl Acad. Sci. USA 118, e2020705118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2021_CR30","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","volume":"25","author":"AC Kwan","year":"2022","unstructured":"Kwan, A. C., Olson, D. E., Preller, K. H. & Roth, B. L. The neural basis of psychedelic action. Nat. Neurosci. 25, 1407\u20131419 (2022).","journal-title":"Nat. Neurosci."},{"key":"2021_CR31","doi-asserted-by":"publisher","first-page":"e2022489118","DOI":"10.1073\/pnas.2022489118","volume":"118","author":"N Hesselgrave","year":"2021","unstructured":"Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B. & Thompson, S. M. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc. Natl Acad. Sci. USA 118, e2022489118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2021_CR32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","volume":"26","author":"R Moliner","year":"2023","unstructured":"Moliner, R. et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat. Neurosci. 26, 1032\u20131041 (2023).","journal-title":"Nat. Neurosci."},{"key":"2021_CR33","doi-asserted-by":"publisher","first-page":"109836","DOI":"10.1016\/j.celrep.2021.109836","volume":"37","author":"M de la Fuente Revenga","year":"2021","unstructured":"de la Fuente Revenga, M. et al. Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice. Cell Rep. 37, 109836 (2021).","journal-title":"Cell Rep."},{"key":"2021_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.adf0435","volume":"379","author":"MV Vargas","year":"2023","unstructured":"Vargas, M. V. et al. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science 379, 700\u2013706 (2023).","journal-title":"Science"},{"key":"2021_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1021\/acschemneuro.2c00718","volume":"14","author":"LP Cameron","year":"2023","unstructured":"Cameron, L. P. et al. 5-HT2ARs mediate therapeutic behavioral effects of psychedelic tryptamines. ACS Chem. Neurosci. 14, 351\u2013358 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"2021_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.abl8615","volume":"375","author":"D Cao","year":"2022","unstructured":"Cao, D. et al. Structure-based discovery of nonhallucinogenic psychedelic analogs. Science 375, 403\u2013411 (2022).","journal-title":"Science"},{"key":"2021_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","volume":"610","author":"AL Kaplan","year":"2022","unstructured":"Kaplan, A. L. et al. Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity. Nature 610, 582\u2013591 (2022).","journal-title":"Nature"},{"key":"2021_CR38","doi-asserted-by":"publisher","first-page":"115028","DOI":"10.1016\/j.bcp.2022.115028","volume":"200","author":"AB Casey","year":"2022","unstructured":"Casey, A. B., Cui, M., Booth, R. G. & Canal, C. E. \u2018Selective\u2019 serotonin 5-HT2A receptor antagonists. Biochem. Pharmacol. 200, 115028 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2021_CR39","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1038\/s41467-023-44016-1","volume":"14","author":"J Wallach","year":"2023","unstructured":"Wallach, J. et al. Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential. Nat. Commun. 14, 8221 (2023).","journal-title":"Nat. Commun."},{"key":"2021_CR40","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1126\/science.1123432","volume":"313","author":"NV Weisstaub","year":"2006","unstructured":"Weisstaub, N. V. et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313, 536\u2013540 (2006).","journal-title":"Science"},{"key":"2021_CR41","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41380-021-01159-1","volume":"26","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress. Mol. Psychiatry 26, 6237\u20136252 (2021).","journal-title":"Mol. Psychiatry"},{"key":"2021_CR42","doi-asserted-by":"publisher","first-page":"263310552110338","DOI":"10.1177\/26331055211033847","volume":"16","author":"J Peters","year":"2021","unstructured":"Peters, J. & Olson, D. E. Engineering safer psychedelics for treating addiction. Neurosci. Insights 16, 26331055211033847 (2021).","journal-title":"Neurosci. Insights"},{"key":"2021_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/psymed.2023.0009","volume":"1","author":"JA Heinsbroek","year":"2023","unstructured":"Heinsbroek, J. A., Giannotti, G., Bonilla, J., Olson, D. E. & Peters, J. Tabernanthalog reduces motivation for heroin and alcohol in a polydrug use model. Psychedelic Med. (New Rochelle) 1, 111\u2013119 (2023).","journal-title":"Psychedelic Med. (New Rochelle)"},{"key":"2021_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1021\/jm00342a019","volume":"6","author":"A Kalir","year":"1963","unstructured":"Kalir, A. & Szara, S. Synthesis and pharmacological activity of fluorinated tryptamine derivatives. J. Med. Chem. 6, 716\u2013719 (1963).","journal-title":"J. Med. Chem."},{"key":"2021_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1526-4610.1977.hed1702054.x","volume":"17","author":"WM Herrmann","year":"1977","unstructured":"Herrmann, W. M., Horowski, R., Dannehl, K., Kramer, U. & Lurati, K. Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide. Headache 17, 54\u201360 (1977).","journal-title":"Headache"},{"key":"2021_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","volume":"23","author":"M Pompeiano","year":"1994","unstructured":"Pompeiano, M., Palacios, J. M. & Mengod, G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res. Mol. Brain Res. 23, 163\u2013178 (1994).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"2021_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(85)90857-1","volume":"346","author":"A Pazos","year":"1985","unstructured":"Pazos, A., Cort\u00e9s, R. & Palacios, J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346, 231\u2013249 (1985).","journal-title":"Brain Res."},{"key":"2021_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejphar.2014.11.047","volume":"750","author":"V Alexandrov","year":"2015","unstructured":"Alexandrov, V., Brunner, D., Hanania, T. & Leahy, E. High-throughput analysis of behavior for drug discovery. Eur. J. Pharmacol. 750, 82\u201389 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"2021_CR49","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/0271678X16629483","volume":"37","author":"LM J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen, L. M. et al. Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain. J. Cereb. Blood Flow Metab. 37, 425\u2013434 (2017).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2021_CR50","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen, M. K. et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology 44, 1328\u20131334 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"2021_CR51","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.neuropharm.2019.107933","volume":"167","author":"AL Halberstadt","year":"2020","unstructured":"Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J. & Brandt, S. D. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology 167, 107933 (2020).","journal-title":"Neuropharmacology"},{"key":"2021_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonz\u00e1lez-Maeso","year":"2007","unstructured":"Gonz\u00e1lez-Maeso, J. et al. Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior. Neuron 53, 439\u2013452 (2007).","journal-title":"Neuron"},{"key":"2021_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-physiol-042022-020923","volume":"86","author":"CJ Hatzipantelis","year":"2024","unstructured":"Hatzipantelis, C. J. & Olson, D. E. The effects of psychedelics on neuronal physiology. Annu. Rev. Physiol. 86, 27\u201347 (2024).","journal-title":"Annu. Rev. Physiol."},{"key":"2021_CR54","unstructured":"Brain Initiative Cell Census Network (Allen Institute, accessed December, 2024); www.biccn.org\/"},{"key":"2021_CR55","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","volume":"9","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F., B\u00e4bler, A., Vogel, H. & Hell, D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9, 3897\u20133902 (1998).","journal-title":"Neuroreport"},{"key":"2021_CR56","doi-asserted-by":"publisher","first-page":"e35082","DOI":"10.7554\/eLife.35082","volume":"7","author":"KH Preller","year":"2018","unstructured":"Preller, K. H. et al. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. eLife 7, e35082 (2018).","journal-title":"eLife"},{"key":"2021_CR57","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","volume":"46","author":"F Holze","year":"2021","unstructured":"Holze, F. et al. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology 46, 537\u2013544 (2021).","journal-title":"Neuropsychopharmacology"},{"key":"2021_CR58","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00213-022-06104-w","volume":"239","author":"YA Serra","year":"2022","unstructured":"Serra, Y. A. et al. Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice. Psychopharmacology (Berl.) 239, 1679\u20131687 (2022).","journal-title":"Psychopharmacology (Berl.)"},{"key":"2021_CR59","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41386-022-01324-2","volume":"47","author":"BD P\u0119dzich","year":"2022","unstructured":"P\u0119dzich, B. D. et al. Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice. Neuropsychopharmacology 47, 1304\u20131314 (2022).","journal-title":"Neuropsychopharmacology"},{"key":"2021_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06517-1","author":"HM Dourron","year":"2023","unstructured":"Dourron, H. M. et al. 5-MeO-DMT: an atypical psychedelic with unique pharmacology, phenomenology & risk? Psychopharmacology (Berl.) https:\/\/doi.org\/10.1007\/s00213-023-06517-1 (2023).","journal-title":"Psychopharmacology (Berl.)"},{"key":"2021_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.npp.1300013","volume":"28","author":"Y Zhai","year":"2003","unstructured":"Zhai, Y. et al. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex. Neuropsychopharmacology 28, 45\u201352 (2003).","journal-title":"Neuropsychopharmacology"},{"key":"2021_CR62","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","volume":"20","author":"JL Scruggs","year":"2000","unstructured":"Scruggs, J. L., Patel, S., Bubser, M. & Deutch, A. Y. DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J. Neurosci. 20, 8846\u20138852 (2000).","journal-title":"J. Neurosci."},{"key":"2021_CR63","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1021\/acschemneuro.2c00637","volume":"14","author":"PA Davoudian","year":"2023","unstructured":"Davoudian, P. A., Shao, L.-X. & Kwan, A. C. Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin. ACS Chem. Neurosci. 14, 468\u2013480 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"2021_CR64","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0169-328X(99)00195-3","volume":"71","author":"M Ma\u0107kowiak","year":"1999","unstructured":"Ma\u0107kowiak, M., Chocyk, A., Fija\u0142, K., Czyrak, A. & Wedzony, K. c-Fos proteins, induced by the serotonin receptor agonist DOI, are not expressed in 5-HT2A positive cortical neurons. Brain Res. Mol. Brain Res. 71, 358\u2013363 (1999).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"2021_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-024-02375-7","author":"R Zhang","year":"2024","unstructured":"Zhang, R. et al. Rapid, biochemical tagging of cellular activity history in vivo. Nat. Methods https:\/\/doi.org\/10.1038\/s41592-024-02375-7 (2024).","journal-title":"Nat. Methods"},{"key":"2021_CR66","doi-asserted-by":"publisher","first-page":"1391412","DOI":"10.3389\/fphar.2024.1391412","volume":"15","author":"E Lerer","year":"2024","unstructured":"Lerer, E. et al. Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: interaction with serotonergic receptor modulators. Front. Pharmacol. 15, 1391412 (2024).","journal-title":"Front. Pharmacol."},{"key":"2021_CR67","doi-asserted-by":"publisher","first-page":"10800","DOI":"10.1523\/JNEUROSCI.23-34-10800.2003","volume":"23","author":"J Alder","year":"2003","unstructured":"Alder, J. et al. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J. Neurosci. 23, 10800\u201310808 (2003).","journal-title":"J. Neurosci."},{"key":"2021_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnbeh.2017.00112","volume":"11","author":"R Chandra","year":"2017","unstructured":"Chandra, R. & Lobo, M. K. Beyond neuronal activity markers: select immediate early genes in striatal neuron subtypes functionally mediate psychostimulant addiction. Front. Behav. Neurosci. 11, 112 (2017).","journal-title":"Front. Behav. Neurosci."},{"key":"2021_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuropharm.2012.06.043","volume":"64","author":"DM Fass","year":"2013","unstructured":"Fass, D. M. et al. Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity. Neuropharmacology 64, 81\u201396 (2013).","journal-title":"Neuropharmacology"},{"key":"2021_CR70","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","volume":"23","author":"J Gonz\u00e1lez-Maeso","year":"2003","unstructured":"Gonz\u00e1lez-Maeso, J. et al. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J. Neurosci. 23, 8836\u20138843 (2003).","journal-title":"J. Neurosci."},{"key":"2021_CR71","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnmol.2015.00078","volume":"8","author":"K Minatohara","year":"2016","unstructured":"Minatohara, K., Akiyoshi, M. & Okuno, H. Role of immediate-early genes in synaptic plasticity and neuronal ensembles underlying the memory trace. Front. Mol. Neurosci. 8, 78 (2016).","journal-title":"Front. Mol. Neurosci."},{"key":"2021_CR72","first-page":"1","volume":"50","author":"S Kim","year":"2018","unstructured":"Kim, S., Kim, H. & Um, J. W. Synapse development organized by neuronal activity-regulated immediate-early genes. Exp. Mol. Med. 50, 1\u20137 (2018).","journal-title":"Exp. Mol. Med."},{"key":"2021_CR73","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41467-023-44503-5","volume":"15","author":"E Bahl","year":"2024","unstructured":"Bahl, E. et al. Using deep learning to quantify neuronal activation from single-cell and spatial transcriptomic data. Nat. Commun. 15, 779 (2024).","journal-title":"Nat. Commun."},{"key":"2021_CR74","doi-asserted-by":"publisher","first-page":"108166","DOI":"10.1016\/j.isci.2023.108166","volume":"26","author":"Y Yan","year":"2023","unstructured":"Yan, Y. et al. Single-cell profiling of glial cells from the mouse amygdala under opioid dependent and withdrawal states. iScience 26, 108166 (2023).","journal-title":"iScience"},{"key":"2021_CR75","doi-asserted-by":"publisher","first-page":"e13403","DOI":"10.1111\/adb.13403","volume":"29","author":"ME Fox","year":"2024","unstructured":"Fox, M. E. et al. Transcriptional signatures of fentanyl use in the mouse ventral tegmental area. Addict. Biol. 29, e13403 (2024).","journal-title":"Addict. Biol."},{"key":"2021_CR76","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/s41593-024-01748-7","volume":"27","author":"J Muir","year":"2024","unstructured":"Muir, J. et al. Sex-biased neural encoding of threat discrimination in nucleus accumbens afferents drives suppression of reward behavior. Nat. Neurosci. 27, 1966\u20131976 (2024).","journal-title":"Nat. Neurosci."},{"key":"2021_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2020.11.013","volume":"42","author":"LL Donovan","year":"2021","unstructured":"Donovan, L. L. et al. Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig. Eur. Neuropsychopharmacol. 42, 1\u201311 (2021).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"2021_CR78","doi-asserted-by":"publisher","first-page":"e2416106122","DOI":"10.1073\/pnas.2416106122","volume":"122","author":"JR Tuck","year":"2025","unstructured":"Tuck, J. R. et al. Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential. Proc. Natl Acad. Sci. USA 122, e2416106122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2021_CR79","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/bdd.317","volume":"23","author":"R Krishna","year":"2002","unstructured":"Krishna, R., Palme, H., Zeng, J. & Srinivas, N. Effect of dose and input rate on the brain penetration of BMS-204352 following intravenous administration to rats. Biopharm. Drug Dispos. 23, 227\u2013231 (2002).","journal-title":"Biopharm. Drug Dispos."},{"key":"2021_CR80","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1213\/ANE.0000000000005835","volume":"134","author":"MA Brito","year":"2022","unstructured":"Brito, M. A. et al. Cortical acetylcholine levels correlate with neurophysiologic complexity during subanesthetic ketamine and nitrous oxide exposure in rats. Anesth. Analg. 134, 1126\u20131139 (2022).","journal-title":"Anesth. Analg."},{"key":"2021_CR81","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/s41467-025-56850-6","volume":"16","author":"F Aboharb","year":"2025","unstructured":"Aboharb, F. et al. Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression. Nat. Commun. 16, 1590 (2025).","journal-title":"Nat. Commun."},{"key":"2021_CR82","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1021\/jm000339w","volume":"43","author":"JB Blair","year":"2000","unstructured":"Blair, J. B. et al. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. J. Med. Chem. 43, 4701\u20134710 (2000).","journal-title":"J. Med. Chem."},{"key":"2021_CR83","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","volume":"21","author":"A Mathis","year":"2018","unstructured":"Mathis, A. et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat. Neurosci. 21, 1281\u20131289 (2018).","journal-title":"Nat. Neurosci."},{"key":"2021_CR84","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41596-019-0176-0","volume":"14","author":"T Nath","year":"2019","unstructured":"Nath, T. et al. Using DeepLabCut for 3D markerless pose estimation across species and behaviors. Nat. Protoc. 14, 2152\u20132176 (2019).","journal-title":"Nat. Protoc."},{"key":"2021_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-022-01443-0","author":"J Lauer","year":"2022","unstructured":"Lauer, J. et al. Multi-animal pose estimation, identification and tracking with DeepLabCut. Nat. Methods https:\/\/doi.org\/10.1038\/s41592-022-01443-0 (2022).","journal-title":"Nat. Methods"},{"key":"2021_CR86","first-page":"e3769","volume":"59","author":"A Can","year":"2012","unstructured":"Can, A. et al. The tail suspension test. J. Vis. Exp. 59, e3769 (2012).","journal-title":"J. Vis. Exp."},{"key":"2021_CR87","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nsmb.3014","volume":"22","author":"WK Kroeze","year":"2015","unstructured":"Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362\u2013369 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2021_CR88","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","volume":"16","author":"RHJ Olsen","year":"2020","unstructured":"Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841\u2013849 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"2021_CR89","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nprot.2011.361","volume":"6","author":"SA Golden","year":"2011","unstructured":"Golden, S. A., Covington, H. E. 3rd, Berton, O. & Russo, S. J. A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 6, 1183\u20131191 (2011).","journal-title":"Nat. Protoc."},{"key":"2021_CR90","doi-asserted-by":"publisher","unstructured":"Pachitariu, M. et al. Suite2p: beyond 10,000 neurons with standard two-photon microscopy. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/061507 (2016).","DOI":"10.1101\/061507"},{"key":"2021_CR91","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/s41386-023-01613-4","volume":"48","author":"DR Rijsketic","year":"2023","unstructured":"Rijsketic, D. R. et al. UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice. Neuropsychopharmacology 48, 1798\u20131807 (2023).","journal-title":"Neuropsychopharmacology"},{"key":"2021_CR92","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12974-024-03306-1","volume":"21","author":"AK Evans","year":"2024","unstructured":"Evans, A. K. et al. Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer\u2019s disease. J. Neuroinflammation 21, 322 (2024).","journal-title":"J. Neuroinflammation"},{"key":"2021_CR93","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12021-020-09490-8","volume":"19","author":"J Perens","year":"2021","unstructured":"Perens, J. et al. An optimized mouse brain atlas for automated mapping and quantification of neuronal activity using iDISCO+ and light sheet fluorescence microscopy. Neuroinformatics 19, 433\u2013446 (2021).","journal-title":"Neuroinformatics"},{"key":"2021_CR94","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"2021_CR95","doi-asserted-by":"publisher","first-page":"giaa151","DOI":"10.1093\/gigascience\/giaa151","volume":"9","author":"MD Young","year":"2020","unstructured":"Young, M. D. & Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience 9, giaa151 (2020).","journal-title":"Gigascience"},{"key":"2021_CR96","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41586-023-06812-z","volume":"624","author":"Z Yao","year":"2023","unstructured":"Yao, Z. et al. A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain. Nature 624, 317\u2013332 (2023).","journal-title":"Nature"},{"key":"2021_CR97","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2021_CR98","doi-asserted-by":"publisher","unstructured":"Aarrestad, I. et al. 2025 Psychoplastogen paper. figshare https:\/\/doi.org\/10.6084\/m9.figshare.26999302 (2025).","DOI":"10.6084\/m9.figshare.26999302"},{"key":"2021_CR99","doi-asserted-by":"publisher","unstructured":"Rijsketic, D. R. & The Heifets Lab. b-heifets\/UNRAVEL: v0.1.2-feature-branch. Zenodo https:\/\/doi.org\/10.5281\/zenodo.13377341 (2024).","DOI":"10.5281\/zenodo.13377341"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02021-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T22:02:59Z","timestamp":1757023379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02021-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":99,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-02021-1","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.E.O. is a cofounder of Delix Therapeutics, Inc., serves as the chief innovation officer and head of the scientific advisory board, and has had sponsored research agreements with Delix Therapeutics. Delix Therapeutics has licensed TBG-related technology from the University of California, Davis. C. Liston is a member of the scientific advisory board of Delix Therapeutics. The sponsors of this research were not involved in the conceptualization, design, decision to publish or preparation of the manuscript. However, several employees of Delix Therapeutics are coauthors of this article as they collected and analyzed data and approved the final version of the manuscript. Within the last 3 years, G.M.K. has been an advisor for Sanos, Onsero, Pangea Botanica, Gilgamesh and Seaport. At the time of manuscript submission, H.D.H. was employed by H. Lundbeck A\/S. B.D.H. is on the scientific advisory board of Osmind and Journey Clinical and is a paid advisor to Arcadia Medicine, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}